Citi Opens Positive Catalyst Watch on Ardelyx, Inc (ARDX), 'Probability of Xphozah Approval >95%'
Tweet Send to a Friend
Citi analyst Yigal Nochomovitz reiterated a Buy rating and $7.00 price target on Ardelyx, Inc (NASDAQ: ARDX).The analyst comments "We ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
